Faulty mitochondria cause deadly diseases: fixing them is about to get a lot easier

CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in.

Gemma Conroy
1. Gemma Conroy is a freelance science journalist based in Mexico City.
View author publications

Search author on: PubMed Google Scholar

CRISPR gene editing has made its way into every corner of modern biology, but not into every corner of the cell. Although researchers have used these systems to develop treatments for sickle-cell anaemia and blood cancers, to unlock the secrets of multicellularity and to discover the role of thousands of overlooked proteins, there’s one place CRISPR can’t easily reach: mitochondria.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 646, 530-532 (2025)

doi: https://doi.org/10.1038/d41586-025-03307-x

Clarification 12 November 2025: This story has been amended to name Liang Chen’s primary affiliation.

Gorman, G. S. et al. Nature Rev. Dis. Primers 2, 16080 (2016).
Article PubMed Google Scholar
Srivastava, S. & Moraes, C. T. Hum. Mol. Genet. 10, 3093–3099 (2001).
Article PubMed Google Scholar
Parakatselaki, M.-E. & Ladoukakis, E. D. Life 11, 633 (2021).
Article PubMed Google Scholar
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris J. A. & Liu, D. R. Nature 533, 420–424 (2016).
Article PubMed Google Scholar
Mok, B. Y. et al. Nature 583, 631–637 (2020).
Article PubMed Google Scholar
Cho, S.-I. et al. Cell 185, 1764–1776 (2022).
Article PubMed Google Scholar
Fan, Y. et al. Nature Biotechnol. https://doi.org/10.1038/s41587-025-02608-w (2025).
Article Google Scholar
Zhang, X. et al. Nature 639, 735–745 (2025).
Article PubMed Google Scholar
Chen, L. et al. Nature Biotechnol. https://doi.org/10.1038/s41587-025-02684-y (2025).
Article Google Scholar